Centre for Targeted Protein Degradation
Job Reference:
SLSC1057
Closing Date:
Thursday, April 21, 2022
Salary:
£33,309 - £40,927
We are seeking 2x Scientists with research experience in organic synthesis and/or medicinal chemistry to join an industry-academia, multi-disciplinary drug discovery team based in the new Centre for Targeted Protein Degradation (CeTPD) within Dundee’s School of Life Sciences.
The team is engaged in a major and expanding collaboration on proteolysis-targeting chimeras (PROTAC) drug discovery between the laboratories of Professor Alessio Ciulli (http://www.lifesci.dundee.ac.uk/groups/alessio-ciulli) and Boehringer Ingelheim. Our mission is to discover novel small-molecule degraders to treat cancer. The scientist will boost the structure guided medicinal chemistry approaches the team are taking to accelerate translation of research in this field and to develop degrader drug candidates.
This is a unique opportunity to gain experience in world-leading industry-style drug discovery within an academic setting. The post may also provide opportunities for short work placements at Boehringer Ingelheim’s research site.
The position is available until 31st December 2023 in the first instance and is available to start immediately.
Please click here to view more.